#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibromatosis Solitary fibrous tumour Acute lymphocytic leukaemia Aicardi-Goutieres syndrome Squamous cell carcinoma of the oral cavity Essential thrombocythaemia Ventricular tachycardia Kearns-Sayre syndrome Congenital megacolon Haemophilia A with anti factor VIII Hyperinsulinism Arteriovenous malformation Glomerulonephritis membranous Postprandial hypoglycaemia Extra-osseous Ewing's sarcoma metastatic More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Life with Disease Antithrombin III deficiency – Treatment Chondrosarcoma metastatic – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information Wolfram syndrome – Basic Information Encephalitis autoimmune Paraneoplastic neurological syndrome – Trials in Disease Arterial tortuosity syndrome Alport’s syndrome – Treatment Mitochondrial myopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Medroxyprogesterone Acetate Ferrous Sulfate Perflutren Digoxin Bms-986315 Aluminium Hydroxide Cd19-Car_Lenti_Allo Teriparatide Camphor Pravastatin Sodium Topotecan Hydrochloride Daplusiran Satoreotide Tetraxetan Eliglustat Tartrate Dupilumab LY4170156 Rbl027.2 Ima203Cd8 Tabelecleucel Apitegromab More therapies…

    Learn about Your Condition

    Cervix carcinoma stage II Fabry's disease Acute myocardial infarction Neuropathic arthropathy Spinal pain Gender dysphoria Ependymoma malignant Renal cancer Thymoma malignant Radiation skin injury Prolymphocytic leukaemia Vaginal infection Hyperadrenocorticism Transplant rejection Mitral valve prolapse More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Comparison of Propofol sedation versus Bupivacaine spinal analgesia in patients undergoing External Cephalic Version procedure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • External cephalic version
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Propofol
    • Fentanyl Citrate
    Spain

  • Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    • Folic Acid
    • Etanercept
    • Methylprednisolone
    Poland

  • Study on the Effectiveness of Carboplatin, Paclitaxel, and Pembrolizumab for Patients with Advanced Penile Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Penile cancer
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    • Pembrolizumab
    Belgium The Netherlands

  • Study on Pramipexole for Patients with Resistant Obsessive-Compulsive Disorder (OCD)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Obsessive-compulsive disorder
    Investigated Drugs:
    • Pramipexole Dihydrochloride Monohydrate
    Portugal

  • Study on the Safety and Effectiveness of Nivolumab, Pembrolizumab, and Cemiplimab with Radiotherapy for Stage IV Non-Small Cell Lung Cancer Patients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    • Nivolumab
    • Cemiplimab
    Norway

  • Study comparing preoperative drug combination with irinotecan, fluorouracil, calcium folinate and oxaliplatin for patients with locally advanced resectable rectal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Calcium Folinate
    • Fluorouracil
    France
Previous Page
1 … 486 487 488 489 490 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!